BRAF and thyroid tumor: Indeed, CCL21 was significantly associated with lymphocyte infiltration in an RNA sequencing study using clinical samples from patients with T1N0 and T2-3N1 thyroid tumors carrying wildtype BRAF and the V600E mutation 50.